Similarities and differences between the vascular endothelial growth factor (VEGF) splice variants

Cancer and Metastasis Reviews

Volumn 15, Issue 2, 1996, Pages 153-158

  Neufeld, Gera ^a   Cohen, Tzafra ^a   Gitay Goren, Hela ^a   Poltorak, Zoya ^a   Tessler, Shoshana ^a   Sharon, Rivka ^a   Gengrinovitch, Stella ^a   Levi, Ben Zion ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Differential receptor recognition; Endothelial cells; Heparin; VEGF isoforms; VEGF receptors

Indexed keywords

HEPARIN; PLATELET DERIVED GROWTH FACTOR; VASCULOTROPIN;

ALTERNATIVE RNA SPLICING; ANGIOGENESIS; BLOOD VESSEL PERMEABILITY; CROSS LINKING; ENDOTHELIUM CELL; EXON; EXTRACELLULAR MATRIX; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN STRUCTURE; PROTEIN VARIANT; RECEPTOR AFFINITY; RECEPTOR BINDING; REVIEW;

ALTERNATIVE SPLICING; ANIMALS; ENDOTHELIAL GROWTH FACTORS; EXONS; HUMANS; ISOMERISM; LYMPHOKINES; STRUCTURE-ACTIVITY RELATIONSHIP; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0030054913     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00437467     Document Type: Review

References (48)

1. Folkman J: What is the evidence that tumors are angiogenesis dependent. J Nat Cancer Inst 82: 4-7, 1990
2. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med 1: 27-31, 1995
3. Rak JW, Stcroix BD, Kerbel RS: Consequences of angiogenesis for tumor progression, metastasis, and cancer therapy. Anti-Cancer Drug 6: 3-18, 1995
4. Ferrara N, Henzel WJ: Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 161: 851-858, 1989
5. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246: 1306-1309, 1989
6. Tischer E, Gospodarowicz D, Mitchell R, Silva M, Schilling J, Lau K, Crisp T, Fiddes JC, Abraham JA: Vascular endothelial growth factor: a new member of the platelet-derived growth factor gene family. Biochem Biophys Res Commun 165: 1198-1206, 1989
7. Gospodarowicz D, Abraham JA, Schilling J: Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells. Proc Natl Acad Sci USA 86: 7311-7315, 1989
8. Connolly DT, Olander JV, Heuvelman D, Nelson R, Monsell R, Siegel N, Haymore BL, Leimgruber R, Feder J: Human vascular permeability factor. Isolation from U937 cells. J Biol Chem 264: 20017-20024, 1989
9. Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J, Connolly DT: Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246: 1309-1312, 1989
10. Maglione D, Guerriero V, Viglietto G, Delli-Bovi P, Persico MG: Isolation of a human placental cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci USA 88: 9267-9271, 1991
11. Guidi AJ, Abujawdeh G, Berse B, Jackman RW, Tognazzi K, Dvorak HF, Brown LF: Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia. J Nat Cancer Inst 87: 1237-1245, 1995
12. Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Dvorak HF, Senger DR: Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am J Pathol 143: 1255-1262, 1993
13. Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Senger DR, Dvorak HF: Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res 53: 4727-4735, 1993
14. Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS, Ferrara N: Inhibition of vascular endothelial growth factor induced angiogenesis suppresses tumour growth in vivo. Nature 362: 841-844, 1993
15. Ferrara N, Winer J, Burton T, Rowland A, Siegel M, Phillips HS, Terrell T, Keller GA, Levinson AD: Expression of vascular endothelial growth factor does not promote transformation but confers a growth advantage in vivo to Chinese hamster ovary cells. J Clin Invest 91: 160-170, 1993
16. Neufeld G, Tessler S, Gitay-Goren H, Cohen T, Levi BZ: Vascular endothelial growth factor and its receptors. Prog Growth Factor Res 5: 89-97: 1994
17. Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D, Fiddes JC, Abraham JA: The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 266: 11947-11954, 1991
18. Houck KA, Ferrara N, Winer J, Cachianes G, Li B, Leung DW: The vascular endothelial growth factor family - identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 5: 1806-1814, 1991
19. Charnock-Jones SD, Sharkey AM, Rajput-Williams J, Burch D, Schofield JP, Fountain SA, Boocock C, Smith SK: Identification and localization of alternatively spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines. Biol Reprod 48: 1120-1128, 1993
20. Bacic M, Edwards NA, Merrill MJ: Differential expression of vascular endothelial growth factor (vascular permeability factor) forms in rat tissues - short communication. Growth Factors 12: 11-15, 1995
21. Cheung CY, Singh M, Ebaugh MJ, Brace RA: Vascular endothelial growth factor gene expression in ovine placenta and fetal membranes. Am J Obstet Gynecol 173: 753-759, 1995
22. Anthony FW, Wheeler T, Elcock CL, Pickett M, Thomas EJ: Identification of a specific pattern of vascular endothelial growth factor mRNA expression in human placenta and cultured placental fibroblasts. Placenta 15: 557-561, 1994
23. Plouet J, Schilling J, Gospodarowicz D: Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT-20 cells. EMBO J 8: 3801-3806, 1989
24. DiSalvo J, Bayne ML, Conn G, Kwok PW, Trivedi PG, Soderman DD, Palisi TM, Sullivan KA, Thomas KA: Purification and characterization of a naturally occurring vascular endothelial growth factor placenta growth factor heterodimer. J Biol Chem 270: 7717-7723, 1995
25. Houck KA, Leung DW, Rowland AM, Winer J, Ferrara N: Dual regulation and vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem 267: 26031-26037, 1992
26. Kondo S, Matsumoto T, Yokoyama Y, Ohmori I, Suzuki H: The shortest isoform of human vascular endothelial growth factor vascular permeability factor (VEGF/VPF121) produced by Saccharomyces cerevisiae promotes both angiogenesis and vascular permeability. Bba-Gen Subjects 1243: 195-202, 1995
27. Gengrinovitch S, Greenberg SM, Cohen T, Gitay-Goren H, Rockwell P, Maione TE, Levi B-Z, Neufeld G: Platelet factor-4 inhibits the mitogenic activity of VEGF-121 and VEGF-165 using several concurrent mechanisms. J Biol Chem 270: 15059-15065, 1995
28. Park JE, Keller GA, Ferrara N: Vascular endothelial growth factor (Vegf) isoforms - differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol Biol Cell 4: 1317-1326, 1993
29. Simon M, Grone HJ, Johren O, Kullmer J, Plate KH, Risau W, Fuchs E: Expressin of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney. Amer J Physiol-Renal F1 Elect 37: F240-F250, 1995
30. Morii K, Tanaka R, Washiyama K, Kumanishi T, Kuwano R: Expression of vascular endothelial growth factor in capillary hemangioblastoma. Biochem Biophys Res Commun 194: 749-755, 1993
31. Harrison-Woolrych ML, Sharkey AM, Charnock-Jones DS, Smith SK: Localization and quantification of vascular endothelial growth factor messenger ribonucleic acid in human myometrium and leiomyomata. J Clin Endocrinol Metab 80: 1853-1858, 1995
32. Cohen T, Gitay-Goren H, Sharon R, Shibuya M, Halaban R, Levi B-Z, Neufeld G: VEGF121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell surface heparan sulfates for efficient binding to the VEGF receptors of human melanoma cells. J Biol Chem 270: 11322-11326, 1995
33. Cohen T, Gitay-Goren H, Neufeld G, Levi B-Z: High levels of biologically active vascular endothelial growth factor (VEGF) are produced by the baculovirus expression system. Growth Factors 7: 131-138, 1992
34. Ferrara N, Houck K, Jakeman L, Leung DW: Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 13: 18-32, 1992
35. Vaisman N, Gospodarowicz D, Neufeld G: Characterization of the receptors for vascular endothelial growth factor. J Biol Chem 265: 19461-19466, 1990
36. Gitay-Goren H, Soker S, Vlodavsky I. Neufeld G: The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules. J Biol Chem 267: 6093-6098, 1992
37. Gitay-Goren H, Cohen T, Tessler S, Soker S, Gengrinovitch S, Rockwell P, Klagsbrun M, Levi B-Z, Neufeld G: Selective binding of VEGF121 to one of the three VEGF receptors of vascular endothelial cells. J Biol Chem 271: 5519-5523, 1996
38. Soker S, Fidder H, Neufeld G, Klagsbrun M: Characterization of novel VEGF binding proteins associated with tumor cells that hind VEGF165 hut not VEGF121. J Biol Chem 271: 5761-5767, 1996
39. Devries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT: The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255: 989-991, 1992
40. Millauer B, Shawver LK, Plate KH, Risau W, Ullrich A: Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 367: 576-579, 1994
41. Seetharam L, Gotoh N, Maru Y, Neufeld G, Yamaguchi S, Shibuya M: A unique signal transduction from FLT tyrosine kinase. a receptor for vascular endothelial growth factor (VEGF). Oncogene 10: 135-147, 1995
42. Waltenberger J, Claessonwelsh L, Siegbahn A, Shibuya M, Heldin CH: Different signal transduction properties of KDR and Fitl, two receptors for vascular endothelial growth factor. J Biol Chem 269: 26988-26995, 1994
43. Tessler S, Rockwell P, Cohen T, Levi B-Z, Hicklin D, Witte L, Lemischka IR, Neufeld G: Heparin modulates the interaction of VEGF165 with soluble and cell associated flk-1 receptors. J Biol Chem 269: 12456-12461, 1994
44. Schraufstatter IU, Halsey WA, Hyslop PA, Cochrane CG: In vitro models for the study of oxidant-induced injury of cells in inflammation. Methods Enzymol 163: 328-339, 1988
45. Heck DE, Laskin DL, Gardner CR, Laskin JD: Epidermal growth factor suppresses nitric oxide and hydrogen peroxide production by keratinocytes. Potential role for nitric oxide in the regulation of wound healing. J Biol Chem 267: 21277-21280, 1992
46. Gospodarowicz D, Cheng J: Heparin protects basic and acidic FGF from inactivation. J Cell Physiol 128: 475-484, 1986
47. Volkin DB, Tsai PK, Dabora JM, Gress JO, Burke CJ, Linhardt RJ, Middaugh CR: Physical stabilization of acidic fibroblast growth factor by polyanions. Arch Biochem Biophys 300: 30-41, 1993
48. Vlodavsky I, Hua-Quan M, Danagher P, Ron D: Involvement of heparan-sulfate and related molecules in sequestration and growth promoting activity of fibroblast growth factor. Cancer Metastasis Rev 1996, this issue